192 related articles for article (PubMed ID: 31178256)
1. Genetic correction of induced pluripotent stem cells mediated by transcription activator-like effector nucleases targeting ALPL recovers enzyme activity and calcification in vitro.
Nakano C; Kitabatake Y; Takeyari S; Ohata Y; Kubota T; Taketani K; Kogo M; Ozono K
Mol Genet Metab; 2019 Jun; 127(2):158-165. PubMed ID: 31178256
[TBL] [Abstract][Full Text] [Related]
2. Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in vitro mutagenesis model.
Uday S; Matsumura T; Saraff V; Saito S; Orimo H; Högler W
Bone; 2019 Oct; 127():9-16. PubMed ID: 31146036
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers.
Watanabe A; Karasugi T; Sawai H; Naing BT; Ikegawa S; Orimo H; Shimada T
J Hum Genet; 2011 Feb; 56(2):166-8. PubMed ID: 21179104
[TBL] [Abstract][Full Text] [Related]
4. Two children with hypophosphatasia with a heterozygous c.1559delT variant in the
Kitoh H; Izawa M; Kaneko H; Kitamura A; Matsuyama S; Kato K; Ogi T
Bone Rep; 2022 Dec; 17():101626. PubMed ID: 36217348
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of adults heterozygous for ALPL mutations.
Taillandier A; Domingues C; Dufour A; Debiais F; Guggenbuhl P; Roux C; Cormier C; Cortet B; Porquet-Bordes V; Coury F; Geneviève D; Chiesa J; Colin T; Fletcher E; Guichet A; Javier RM; Laroche M; Laurent M; Lausch E; LeHeup B; Lukas C; Schwabe G; van der Burgt I; Muti C; Simon-Bouy B; Mornet E
J Bone Miner Metab; 2018 Nov; 36(6):723-733. PubMed ID: 29236161
[TBL] [Abstract][Full Text] [Related]
6. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
Koyama H; Yasuda S; Kakoi S; Ohata Y; Shimizu Y; Hasegawa C; Hayakawa A; Akiyama T; Yagi T; Aotani D; Imaeda K; Ozono K; Kataoka H; Tanaka T
Intern Med; 2020 Mar; 59(6):811-815. PubMed ID: 31787692
[TBL] [Abstract][Full Text] [Related]
7. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia.
Foster BL; Sheen CR; Hatch NE; Liu J; Cory E; Narisawa S; Kiffer-Moreira T; Sah RL; Whyte MP; Somerman MJ; Millán JL
J Dent Res; 2015 May; 94(5):706-14. PubMed ID: 25716980
[TBL] [Abstract][Full Text] [Related]
8. Genetic correction of adipose tissue-derived mesenchymal stem cells mediated by TALEN targeting the GDF5 gene.
Li B; Zhang Y; Li M; Zhao X; Xie H; Guo X; Wang F; Xia H; Chen B
Int J Mol Med; 2018 Apr; 41(4):2397-2405. PubMed ID: 29393424
[TBL] [Abstract][Full Text] [Related]
9. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.
Zou J; Mali P; Huang X; Dowey SN; Cheng L
Blood; 2011 Oct; 118(17):4599-608. PubMed ID: 21881051
[TBL] [Abstract][Full Text] [Related]
10. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D
Kinoshita Y; Mohamed FF; Amadeu de Oliveira F; Narisawa S; Miyake K; Foster BL; Millán JL
J Bone Miner Res; 2021 Sep; 36(9):1835-1849. PubMed ID: 34076297
[TBL] [Abstract][Full Text] [Related]
12. In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs.
Wu Y; Hu Z; Li Z; Pang J; Feng M; Hu X; Wang X; Lin-Peng S; Liu B; Chen F; Wu L; Liang D
Sci Rep; 2016 Jan; 6():18865. PubMed ID: 26743572
[TBL] [Abstract][Full Text] [Related]
13. Conditional Alpl Ablation Phenocopies Dental Defects of Hypophosphatasia.
Foster BL; Kuss P; Yadav MC; Kolli TN; Narisawa S; Lukashova L; Cory E; Sah RL; Somerman MJ; Millán JL
J Dent Res; 2017 Jan; 96(1):81-91. PubMed ID: 27582029
[TBL] [Abstract][Full Text] [Related]
14. Mutational and biochemical findings in adults with persistent hypophosphatasemia.
McKiernan FE; Dong J; Berg RL; Scotty E; Mundt P; Larson L; Rai I
Osteoporos Int; 2017 Aug; 28(8):2343-2348. PubMed ID: 28401263
[TBL] [Abstract][Full Text] [Related]
15. Correction of hypophosphatasia-associated mineralization deficiencies in vitro by phosphate/pyrophosphate modulation in periodontal ligament cells.
Rodrigues TL; Foster BL; Silverio KG; Martins L; Casati MZ; Sallum EA; Somerman MJ; Nociti FH
J Periodontol; 2012 May; 83(5):653-63. PubMed ID: 22014174
[TBL] [Abstract][Full Text] [Related]
16. Molecular phenotype of tissue-nonspecific alkaline phosphatase with a proline (108) to leucine substitution associated with dominant odontohypophosphatasia.
Numa-Kinjoh N; Komaru K; Ishida Y; Sohda M; Oda K
Mol Genet Metab; 2015 Aug; 115(4):180-5. PubMed ID: 25982064
[TBL] [Abstract][Full Text] [Related]
17. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
Whyte MP; McAlister WH; Mumm S; Bierhals AJ
Bone; 2019 May; 122():231-236. PubMed ID: 30825650
[TBL] [Abstract][Full Text] [Related]
18. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia.
Ogawa E; Shimura K; Yoshihashi H; Miyama S
Pediatr Neurol; 2022 May; 130():4-6. PubMed ID: 35303588
[TBL] [Abstract][Full Text] [Related]
19. A Case of the Perinatal Form Hypophosphatasia Caused by a Novel Large Duplication of the
Hacıhamdioğlu B; Özgürhan G; Pereira C; Tepeli E; Acar G; Cömert S
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):306-310. PubMed ID: 30468149
[TBL] [Abstract][Full Text] [Related]
20. Hypophosphatasia: From Diagnosis to Treatment.
Simon S; Resch H; Klaushofer K; Roschger P; Zwerina J; Kocijan R
Curr Rheumatol Rep; 2018 Sep; 20(11):69. PubMed ID: 30203264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
